169 related articles for article (PubMed ID: 33392617)
1. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma.
Tsai YL; Takei H; Iizumi T; Okumura T; Sekino Y; Numajiri H; Ishikawa H; Sakae T; Sakurai H
J Radiat Res; 2021 Jan; 62(1):133-141. PubMed ID: 33392617
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Lee SU; Park JW; Kim TH; Kim YJ; Woo SM; Koh YH; Lee WJ; Park SJ; Kim DY; Kim CM
Strahlenther Onkol; 2014 Sep; 190(9):806-14. PubMed ID: 24589917
[TBL] [Abstract][Full Text] [Related]
4. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
[TBL] [Abstract][Full Text] [Related]
5. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy in Liver Malignancies.
Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization.
Shirai S; Sato M; Suwa K; Kishi K; Shimono C; Sonomura T; Kawai N; Tanihata H; Minamiguchi H; Nakai M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1037-44. PubMed ID: 19540053
[TBL] [Abstract][Full Text] [Related]
8. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
9. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
[TBL] [Abstract][Full Text] [Related]
10. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
11. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
13. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
[TBL] [Abstract][Full Text] [Related]
15. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
[TBL] [Abstract][Full Text] [Related]
16. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
18. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
20. Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.
Yang AH; Urrunaga NH; Siddiqui O; Wu A; Schliep M; Mossahebi S; Shetty K; Regine WF; Molitoris JK; Lominadze Z
J Radiosurg SBRT; 2023; 9(1):43-52. PubMed ID: 38029012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]